2017-01-12,Short Interest Increases 10.3% For BMRN
2017-01-10,Sarepta Opens Up About Duchenne Drug Launch, Allays Investors' Worst Fears
2017-01-09,Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference
2017-01-05,What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017
2017-01-03,Biotech Should Witness M&amp;A's Return in 2017
2016-12-15,Johnson & Johnson Looks for New Deal That's Just Right
2016-12-12,BioMarin Enrolls First Participant In Phase 3 Trial Of Vosoritide For Treatment Of Children With Achondroplasia
2016-11-29,BioMarin Surging Beneath the Surface
2016-11-13,Six Thoughts on President Trump and the Durability of the Biotech Stock Rally
2016-11-07,Analysts' Actions -- Biogen, GoPro, L Brands, Time Warner and More
2016-11-03,BioMarin To Attend Three Upcoming Investor Conferences
2016-10-27,BioMarin Announces Third Quarter 2016 Financial Results
2016-10-26,BioMarin Pharmaceutical Becomes #19 Most Shorted Nasdaq 100 Component, Replacing Dish Network
2016-10-19,BioMarin Presents Vosoritide Data In Achondroplasia At American Society Of Human Genetics (ASHG) 2016 Meeting
2016-10-17,PTC Therapeutics Getting Cold Shoulder From Regulators on Duchenne Drug Appeal
2016-10-13,UK Regulatory Agency Approves Continued Enrollment In BioMarin Phase 1/2 Study Of BMN 270 In Hemophilia A
2016-10-13,Pardon Me, but I Have a Few Things to Say... Seattle Genetics, Biomarin, Sarepta, TG Therapeutics
2016-10-11,BioMarin To Host Third Quarter 2016 Financial Results Conference Call And Webcast On Thursday, October 27 At 4:30pm ET
2016-09-22,New Setback for Sanofi's Lantus Increases Need for M&amp;A
2016-09-21,BioMarin Reviews Status Of Exon 51 Composition Of Matter And Method Of Use Patent Interference Cases Against Sarepta Therapeutics
2016-09-20,Biotech Stock Mailbag: Sarepta Therapeutics Approval Edition
2016-09-15,BioMarin Announces EMA Validation Of Brineura™ (Cerliponase Alfa) Marketing Authorization Application For Treatment Of CLN2 Disease, A Form Of Batten Disease
2016-09-14,These 5 Biotech Stocks Are Ready for a Volatility Break
2016-09-08,BioMarin Announces Two Oral And 16 Poster Presentations At Society For The Study Of Inborn Errors Of Metabolism 2016 Annual Meeting
2016-09-06,BioMarin Announces Update To Brineura™ (Cerliponase Alfa) Program For Treatment Of CLN2 Disease, A Form Of Batten Disease
2016-08-31,BioMarin To Attend Upcoming Investor Conferences
2016-08-24,Forbes Ranks BioMarin 10th Most Innovative Company In The World
2016-08-22,BioMarin (BMRN) Stock Surges on Takeover Speculation
2016-08-22,Facebook Stands Out and FormFactor Has a Good Start
2016-08-09,BioMarin Announces Pricing Of Public Offering Of Common Stock
2016-08-08,Cramer: Companies Are Issuing a Lot of Paper
2016-08-08,BioMarin (BMRN) Stock Tumbles in After-Hours Trading on Public Offering
2016-08-08,BioMarin Announces Public Offering Of Common Stock
2016-08-04,Trade-Ideas: Biomarin Pharmaceutical (BMRN) Is Today's Post-Market Leader Stock
2016-08-04,BioMarin Announces Second Quarter 2016 Financial Results
2016-08-01,Cramer: What Are You Thinking? It Should Be Long Term
2016-07-27,FDA Accepts BLA For BioMarin's Cerliponase Alfa For CLN2 Disease, Form Of Batten Disease
2016-07-27,Biomarin Hemophilia Gene Therapy Advances on Strong Study Results
2016-07-27,BioMarin Provides Positive Proof-of-Concept Data For BMN 270 Gene Therapy In Hemophilia A In Late Breaking Oral Presentation At The World Federation Of Hemophilia (WFH) 2016 World Congress
2016-07-21,BioMarin To Provide Updated Data For BMN 270 In Hemophilia A In Late Breaking Oral Presentation At The World Federation Of Hemophilia (WFH) 2016 World Congress July 27th
2016-07-21,Roche Beats First-Half Forecasts as Cancer Drug Sales Rise
2016-07-18,BioMarin Appoints Two BioPharmaceutical Veterans To Board Of Directors, Willard Dere, M.D. And Kathryn E. Falberg
2016-07-15,3 Stocks Driving The Drugs Industry Higher
2016-07-14,BioMarin To Host Second Quarter 2016 Financial Results Conference Call And Webcast On Thursday, August 4 At 4:30pm ET
2016-07-11,Cramer: 11 Reasons Why the Market Turned
2016-07-08,Biomarin Pharmaceutical (BMRN) Highlighted As Storm The Castle Stock
2016-07-07,Closing Bell: Humana Slumps on Deal Worries; U.S. Stocks Mixed
2016-07-07,BioMarin (BMRN) Stock Soars on Takeover Speculation
2016-07-07,Biomarin Pharmaceutical (BMRN) Trading With Heavy Volume Before Market Open
2016-07-07,Medivation Tries to Prove Its Worth
2016-07-06,Trade-Ideas: Biomarin Pharmaceutical (BMRN) Is Today's Post-Market Leader Stock
2016-07-01,Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here
2016-06-29,16 Biopharma Companies Besides Medivation That Are Attractive Targets
2016-06-24,RBC sees biopharma 'insulated' from Brexit, says buy Celgene for bounceback
2016-06-20,BioMarin Announces Acceptance Of Late Breaking Abstract For BMN 270 At The World Federation Of Hemophilia (WFH) 2016 World Congress July 27 In Orlando, FL
2016-06-17,BioMarin Pharmaceuticals Jumps on Takeover Talk
2016-06-17,BioMarin Takeout Rumors Swirl, Industry Insiders Aren't Convinced
2016-06-16,Why BioMarin (BMRN) Stock Is Lower Today
2016-06-15,3 Drugs Stocks Driving The Industry Higher
2016-06-15,Biomarin Pharmaceutical (BMRN) Is Today's Strong On High Volume Stock
2016-06-08,3 Stocks Dragging In The Health Care Sector
2016-05-31,BioMarin Announces Withdrawal Of Market Authorization Application For Kyndrisa™ (drisapersen) In Europe
2016-05-31,3 Health Care Stocks Pushing Sector Growth
2016-05-26,Insider Trading Alert - SUM, KLXI And BMRN Traded By Insiders
2016-05-25,The New #24 Most Shorted Nasdaq 100 Component: BioMarin Pharmaceutical
2016-05-25,A 'What's Next?' Scenario for the Delayed Sarepta Duchenne Drug Review
2016-05-16,AbSci Appoints Daniel Gold, Ph.D. To Board Of Directors
2016-05-05,3 Stocks Pulling The Drugs Industry Downward
2016-05-04,BioMarin To Attend Upcoming Investor Conferences
2016-05-03,Biogen's Hemophilia Franchise IPO Is Disappointing
2016-05-03,BioMarin Pharmaceutical Becomes #35 Most Shorted Nasdaq 100 Component, Replacing Monster Beverage
2016-05-03,BioMarin Announces EMA Grants Accelerated Assessment For Cerliponase Alfa, Experimental Treatment For A Form Of Batten Disease
2016-04-29,Sanofi First Quarter Shows Why It Wants but Doesn't Need Medivation
2016-04-28,Biomarin Pharmaceutical (BMRN) Lags In Post-Market Trading
2016-04-28,BioMarin Announces First Quarter 2016 Financial Results
2016-04-28,Sanofi Presses Medivation to Hold Talks After $9.3B Offer
2016-04-22,Biotech Stock Mailbag: Is There a Future for Sarepta Therapeutics?
2016-04-21,BioMarin Enrolls First Patient In Phase 1/2 Trial Of NAGLU Fusion Protein BMN 250 For Treatment Of MPS IIIB (Sanfilippo B Syndrome)
2016-04-21,Jim Cramer's Top Takeaways: Intel, BioMarin Pharmaceuticals
2016-04-20,Jim Cramer's 'Mad Money' Recap: This Market Is Rising No Matter What You Think
2016-04-20,BioMarin Provides Program Update On Vosoritide In Achondroplasia
2016-04-20,BioMarin Provides Encouraging Preliminary Data On First 8 Patients In Hemophilia A Gene Therapy Program
2016-04-18,BioMarin To Highlight Breadth Of Innovative Development Pipeline At R&D Day On April 20th In New York
2016-04-12,BioMarin To Host First Quarter 2016 Financial Results Conference Call And Webcast On Thursday, April 28 At 4:30pm ET
2016-04-12,Anavex Plays the Orphan Drug Stock Promotion Game
2016-04-07,BioMarin (BMRN) Stock is the 'Chart of the Day'
2016-04-07,BioMarin Has Juice Left in the Tank
2016-04-07,Chart of the Day: BioMarin Pharmaceutical
2016-04-01,Sell These 5 Toxic Stocks Now, Before It's Too Late
2016-03-31,Biomarin Pharmaceutical (BMRN) Strong On High Relative Volume Today
2016-03-29,3 Stocks Pushing The Drugs Industry Downward
2016-03-28,A Rolling-Nowhere Market Gathers More Bears
2016-03-24,BioMarin Receives European Orphan Drug Designation For BMN 270, First Investigational AAV-Factor VIII Gene Therapy For Patients With Hemophilia A
2016-03-22,Biomarin Pharmaceutical (BMRN) Strong On High Relative Volume Today
2016-03-21,BioMarin PKU Drug Shows Mixed Results in Pivotal Study
2016-03-21,BioMarin Phase 3 Study Of Pegvaliase For Phenylketonuria (PKU) Meets Primary Endpoint Of Blood Phenylalanine (Phe) Reduction (p
2016-03-17,Insider Trading Alert - BRT, BMRN And CSGS Traded By Insiders
2016-03-12,Biotech Stock Mailbag: Biomarin PKU Preview, Celldex Post-Mortem
2016-03-09,BMRN, INCY And ALXN, Pushing Drugs Industry Downward
2016-03-08,Jim Cramer Says BioMarin Is the Last Bear Market
2016-03-08,Jim Cramer: Bear Markets in Many Sectors Have Ended
2016-03-06,JPMorgan's 7 Best Stock Picks With Near-Term Catalysts
2016-03-03,Biomarin Drug Provides 'Substantial Benefit' to Kids with Rare, Fatal Brain Disease
2016-03-03,BioMarin To Attend Three Upcoming Investor Conferences In March
2016-03-02,BioMarin Announces Positive Data From Cerliponase Alfa Program For Treatment Of CLN2 Disease, A Form Of Batten Disease, At 12th Annual WORLDSymposium(TM) 2016
2016-03-01,BioMarin Receives Orphan Drug Designation From FDA For First AAV-Factor VIII Gene Therapy, BMN 270, For Patients With Hemophilia A
2016-02-29,BioMarin Faces a Key Test of Rare Disease Pipeline
2016-02-29,BioMarin Announces BioMarin RareConnections(TM) Rebranding And Consolidating BioMarin's Comprehensive Support And Services For Eligible Rare Disease Patients
2016-02-29,BioMarin Announces 21 Presentations At 12th Annual WORLDSymposium™ 2016 February 29-March 4 In San Diego, California: 6 Oral And 15 Poster
2016-02-25,Biomarin Pharmaceutical (BMRN) Down In After-Hours Trading
2016-02-25,BioMarin Announces Fourth Quarter And Full Year 2015 Financial Results
2016-02-17,Rally Generates Mixed Emotions So Far
2016-02-08,Trade-Ideas: Biomarin Pharmaceutical (BMRN) Is Today's Post-Market Leader Stock
2016-01-28,Today's Weak On High Volume Stock: Biomarin Pharmaceutical (BMRN)
2016-01-28,BioMarin To Host Fourth Quarter And Full Year 2015 Financial Results Conference Call And Webcast On Thursday, February 25 At 4:30pm ET
2016-01-24,Biotech Stock Mailbag: Snow Stops Sarepta's FDA Show, so What's Next?
2016-01-15,Sarepta Plunges on Harsh FDA Eteplirsen Review Ahead of Next Week's Advisory Panel Meeting
2016-01-14,Today's Dead Cat Bounce Stock Is Biomarin Pharmaceutical (BMRN)
2016-01-14,FDA Issues Complete Response Letter For KyndrisaTM For Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping
2016-01-12,Water-Logged and Getting Wetter Stock of the Day: Biomarin Pharmaceutical (BMRN)
2016-01-11,BioMarin Announces Interim Analysis Of INSPIRE Clinical Trial In Pompe Disease At 34th Annual J.P. Morgan Annual Healthcare Conference
2016-01-09,2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
2016-01-05,BioMarin To Present At 34th Annual J.P. Morgan Healthcare Conference In San Francisco
2016-01-04,BioMarin Announces Addition Of David Pyott, Former Allergan Chairman And CEO, To Company's Board Of Directors
2015-12-26,Sell These 6 Biotech Stocks Now Before It's Too Late
2015-12-19,The Naughty List: Finalists for Worst Biopharma CEO of 2015
2015-12-18,3 Drugs Stocks Pushing Industry Growth
2015-12-18,BioMarin Announces That FDA Has Advised It Will Not Take Action On The Kyndrisa™ (drisapersen) New Drug Application By The PDUFA Date
2015-12-17,3 Convertible Bonds That Belong in Your Portfolio
2015-12-17,Teva, Biomarin Offer Convertible Opportunities Says MainStay Manager
2015-12-02,Biotech Stock Mailbag: Anavex, Northwest Bio, Threshold Therapeutics
2015-11-25,Biomarin Pharmaceutical (BMRN) Down In Early Morning Trading
2015-11-25,BioMarin's Duchenne Drug Is Done, Sarepta Survives but Faces Challenge
2015-11-24,FDA Advisory Committee Discusses Clinical Data Package For BioMarin's Kyndrisa(TM) (drisapersen) For The Treatment Of Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping
2015-11-24,BioMarin Posts Presentation From FDA Advisory Committee Meeting For Kyndrisa(TM) (drisapersen) For The Treatment Of Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping
2015-11-24,BioMarin FDA Panel Live Blog
2015-11-24,BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Announced Today The Stock Is Halted
2015-11-23,NICE Recommends BioMarin's Vimizim® (elosulfase Alfa) For The Treatment Of Morquio A Syndrome In England
2015-11-20,3 Stocks to Buy on Big Volume
2015-11-20,Jim Cramer -- Market Powers Higher Despite the Woes of BioMarin, Mentor Graphics
2015-11-20,BioMarin Duchenne Drug Receives Harsh Review From FDA
2015-11-20,BioMarin Announces Data Analysis Demonstrating Consistent Efficacy Of Kyndrisa™ (drisapersen) In Comparable Patients Across Three Randomized Studies
2015-11-20,FDA Posts Briefing Documents For Advisory Committee Meeting To Review Kyndrisa™ (drisapersen) For The Potential Treatment Of Duchenne Muscular Dystrophy Amendable To Exon 51 Skipping
2015-11-20,Before the Move: Watch BioMarin Into FDA Advisory Committee
2015-11-19,These Biotech Stocks Could Move on BioMarin's Duchenne Drug FDA Panel
2015-11-18,Goldman Sees Bluebird Shares Doubling On 'One-Shot' Gene Therapy
2015-11-18,How to Prepare for BioMarin's (and Biotech's) Biggest Event of 2015
2015-11-16,Ernst & Young Names BioMarin CEO Jean-Jacques Bienaime EY Entrepreneur Of The Year® 2015 National Award Winner In Life Sciences
2015-11-04,Retrophin Sinks, Pharma Group Swings Back As Pricing Fight Escalates
2015-11-02,FDA Letter Raises Questions About Biomarin Handling of Muscular Dystrophy Drug
2015-10-29,BioMarin Announces Third Quarter 2015 Financial Results And Company Update
2015-10-27,BioMarin To Attend Upcoming Investor Conference In November
2015-10-23,Ratings Changes Today
2015-10-16,Investing Moves for a No-Growth World; ETF Distortion: Jim Cramer's Best Blogs
2015-10-16,Biotech Stock Mailbag: New Sarepta Risk, Zafgen Patient Death, Bluebird Gene Therapy Update
2015-10-15,Jim Cramer's 'Mad Money' Recap: Buy Growth Where You Can
2015-10-15,BioMarin To Host Third Quarter 2015 Financial Results Conference Call And Webcast On Thursday, October 29 At 4:30pm ET
2015-10-15,BioMarin Announces FDA Advisory Committee To Review Drisapersen For Treatment Of Patients With Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping
2015-10-14,BioMarin Secures FDA Panel Date for Duchenne Drug but Where is Sarepta? (Update)
2015-10-13,Jim Cramer's Top Takeaways: Helen of Troy, BioMarin, Energy Transfer Partners
2015-10-12,BioMarin's Initial 6-Month Data From Phase 2 Study Of Vosoritide (BMN 111) In Children With Achondroplasia Presented At The American Society For Bone And Mineral Research Annual 2015 Meeting
2015-10-05,Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector
2015-10-01,BioMarin Buys Kuvan Drug Rights From Merck
2015-10-01,Sarepta Unveils New Data to Make Stronger Case for Duchenne Drug Approval
2015-10-01,BioMarin To Acquire Rights To Phenylketonuria (PKU) Franchise From Merck Serono
2015-09-30,BioMarin To Present Research Results On Duchenne Muscular Dystrophy And Pompe Disease Programs At The 20th International Congress Of The World Muscle Society
2015-09-30,BioMarin Pharmaceutical (BMRN) Stock Climbs on Patent Win
2015-09-30,Cramer -- BioMarin's Patent Win Could Spark a Biotech Bounce
2015-09-29,BioMarin Receives Favorable Ruling In The Use Of Exon 51 Antisense Oligonucleotides Patent Interference
2015-09-28,BioMarin Enrolls First Patient In Phase 1/2 Trial Of Gene Therapy Drug Candidate BMN 270 For The Treatment Of Hemophilia A
2015-09-25,RSI Alert: BioMarin Pharmaceutical Now Oversold
2015-09-25,Biotech Stock Mailbag: Rebounding From Hillary's Drug Tweet; Global Blood Weighs on Bluebird
2015-09-22,Biomarin Pharmaceutical (BMRN) Is Today's Roof Leaker Stock
2015-09-22,Analysts Say Buy Select Biotech Stocks Ahead Of Clinton Drug Plan
2015-09-18,BioMarin Announces Kuvan(R) (sapropterin Dihydrochloride) Patent Challenge Settlement
2015-09-10,Is FDA Having Trouble Setting Date for Biomarin, Sarepta Advisory Panels?
2015-09-03,Biotech Stock Mailbag: Sarepta, Biomarin, Spark, Raptor
2015-09-02,BioMarin To Attend Upcoming Investor Conferences In September
2015-09-01,BioMarin Launches KNOWyourDuchenne, Comprehensive Program For Patients With Duchenne Muscular Dystrophy To Understand Their Genetic Mutation
2015-08-31,BioMarin Announces Two Oral And 19 Poster Presentations At The Society For The Study Of Inborn Errors Of Metabolism 2015 Annual Meeting
2017-01-12,Short Interest Increases 10.3% For BMRN
2017-01-10,Sarepta Opens Up About Duchenne Drug Launch, Allays Investors' Worst Fears
2017-01-09,Monday's Sights, Sounds and Biotech Buzz From the J.P. Morgan Healthcare Conference
2017-01-05,What Biotech Investors Can Expect From the J.P. Morgan Health Care Conference 2017
2017-01-03,Biotech Should Witness M&amp;A's Return in 2017
2016-12-15,Johnson & Johnson Looks for New Deal That's Just Right
2016-12-12,BioMarin Enrolls First Participant In Phase 3 Trial Of Vosoritide For Treatment Of Children With Achondroplasia
2016-11-29,BioMarin Surging Beneath the Surface
2016-11-13,Six Thoughts on President Trump and the Durability of the Biotech Stock Rally
2016-11-07,Analysts' Actions -- Biogen, GoPro, L Brands, Time Warner and More
2016-11-03,BioMarin To Attend Three Upcoming Investor Conferences
2016-10-27,BioMarin Announces Third Quarter 2016 Financial Results
2016-10-26,BioMarin Pharmaceutical Becomes #19 Most Shorted Nasdaq 100 Component, Replacing Dish Network
2016-10-19,BioMarin Presents Vosoritide Data In Achondroplasia At American Society Of Human Genetics (ASHG) 2016 Meeting
2016-10-17,PTC Therapeutics Getting Cold Shoulder From Regulators on Duchenne Drug Appeal
2016-10-13,UK Regulatory Agency Approves Continued Enrollment In BioMarin Phase 1/2 Study Of BMN 270 In Hemophilia A
2016-10-13,Pardon Me, but I Have a Few Things to Say... Seattle Genetics, Biomarin, Sarepta, TG Therapeutics
2016-10-11,BioMarin To Host Third Quarter 2016 Financial Results Conference Call And Webcast On Thursday, October 27 At 4:30pm ET
2016-09-22,New Setback for Sanofi's Lantus Increases Need for M&amp;A
2016-09-21,BioMarin Reviews Status Of Exon 51 Composition Of Matter And Method Of Use Patent Interference Cases Against Sarepta Therapeutics
2016-09-20,Biotech Stock Mailbag: Sarepta Therapeutics Approval Edition
2016-09-15,BioMarin Announces EMA Validation Of Brineura™ (Cerliponase Alfa) Marketing Authorization Application For Treatment Of CLN2 Disease, A Form Of Batten Disease
2016-09-14,These 5 Biotech Stocks Are Ready for a Volatility Break
2016-09-08,BioMarin Announces Two Oral And 16 Poster Presentations At Society For The Study Of Inborn Errors Of Metabolism 2016 Annual Meeting
2016-09-06,BioMarin Announces Update To Brineura™ (Cerliponase Alfa) Program For Treatment Of CLN2 Disease, A Form Of Batten Disease
2016-08-31,BioMarin To Attend Upcoming Investor Conferences
2016-08-24,Forbes Ranks BioMarin 10th Most Innovative Company In The World
2016-08-22,BioMarin (BMRN) Stock Surges on Takeover Speculation
2016-08-22,Facebook Stands Out and FormFactor Has a Good Start
2016-08-09,BioMarin Announces Pricing Of Public Offering Of Common Stock
2016-08-08,Cramer: Companies Are Issuing a Lot of Paper
2016-08-08,BioMarin (BMRN) Stock Tumbles in After-Hours Trading on Public Offering
2016-08-08,BioMarin Announces Public Offering Of Common Stock
2016-08-04,Trade-Ideas: Biomarin Pharmaceutical (BMRN) Is Today's Post-Market Leader Stock
2016-08-04,BioMarin Announces Second Quarter 2016 Financial Results
2016-08-01,Cramer: What Are You Thinking? It Should Be Long Term
2016-07-27,FDA Accepts BLA For BioMarin's Cerliponase Alfa For CLN2 Disease, Form Of Batten Disease
2016-07-27,Biomarin Hemophilia Gene Therapy Advances on Strong Study Results
2016-07-27,BioMarin Provides Positive Proof-of-Concept Data For BMN 270 Gene Therapy In Hemophilia A In Late Breaking Oral Presentation At The World Federation Of Hemophilia (WFH) 2016 World Congress
2016-07-21,BioMarin To Provide Updated Data For BMN 270 In Hemophilia A In Late Breaking Oral Presentation At The World Federation Of Hemophilia (WFH) 2016 World Congress July 27th
2016-07-21,Roche Beats First-Half Forecasts as Cancer Drug Sales Rise
2016-07-18,BioMarin Appoints Two BioPharmaceutical Veterans To Board Of Directors, Willard Dere, M.D. And Kathryn E. Falberg
2016-07-15,3 Stocks Driving The Drugs Industry Higher
2016-07-14,BioMarin To Host Second Quarter 2016 Financial Results Conference Call And Webcast On Thursday, August 4 At 4:30pm ET
2016-07-11,Cramer: 11 Reasons Why the Market Turned
2016-07-08,Biomarin Pharmaceutical (BMRN) Highlighted As Storm The Castle Stock
2016-07-07,Closing Bell: Humana Slumps on Deal Worries; U.S. Stocks Mixed
2016-07-07,BioMarin (BMRN) Stock Soars on Takeover Speculation
2016-07-07,Biomarin Pharmaceutical (BMRN) Trading With Heavy Volume Before Market Open
2016-07-07,Medivation Tries to Prove Its Worth
2016-07-06,Trade-Ideas: Biomarin Pharmaceutical (BMRN) Is Today's Post-Market Leader Stock
2016-07-01,Biotech Stock Mailbag: Mid-Year Assessment, Where We Go From Here
2016-06-29,16 Biopharma Companies Besides Medivation That Are Attractive Targets
2016-06-24,RBC sees biopharma 'insulated' from Brexit, says buy Celgene for bounceback
2016-06-20,BioMarin Announces Acceptance Of Late Breaking Abstract For BMN 270 At The World Federation Of Hemophilia (WFH) 2016 World Congress July 27 In Orlando, FL
2016-06-17,BioMarin Pharmaceuticals Jumps on Takeover Talk
2016-06-17,BioMarin Takeout Rumors Swirl, Industry Insiders Aren't Convinced
2016-06-16,Why BioMarin (BMRN) Stock Is Lower Today
2016-06-15,3 Drugs Stocks Driving The Industry Higher
2016-06-15,Biomarin Pharmaceutical (BMRN) Is Today's Strong On High Volume Stock
2016-06-08,3 Stocks Dragging In The Health Care Sector
2016-05-31,BioMarin Announces Withdrawal Of Market Authorization Application For Kyndrisa™ (drisapersen) In Europe
2016-05-31,3 Health Care Stocks Pushing Sector Growth
2016-05-26,Insider Trading Alert - SUM, KLXI And BMRN Traded By Insiders
2016-05-25,The New #24 Most Shorted Nasdaq 100 Component: BioMarin Pharmaceutical
2016-05-25,A 'What's Next?' Scenario for the Delayed Sarepta Duchenne Drug Review
2016-05-16,AbSci Appoints Daniel Gold, Ph.D. To Board Of Directors
2016-05-05,3 Stocks Pulling The Drugs Industry Downward
2016-05-04,BioMarin To Attend Upcoming Investor Conferences
2016-05-03,Biogen's Hemophilia Franchise IPO Is Disappointing
2016-05-03,BioMarin Pharmaceutical Becomes #35 Most Shorted Nasdaq 100 Component, Replacing Monster Beverage
2016-05-03,BioMarin Announces EMA Grants Accelerated Assessment For Cerliponase Alfa, Experimental Treatment For A Form Of Batten Disease
2016-04-29,Sanofi First Quarter Shows Why It Wants but Doesn't Need Medivation
2016-04-28,Biomarin Pharmaceutical (BMRN) Lags In Post-Market Trading
2016-04-28,BioMarin Announces First Quarter 2016 Financial Results
2016-04-28,Sanofi Presses Medivation to Hold Talks After $9.3B Offer
2016-04-22,Biotech Stock Mailbag: Is There a Future for Sarepta Therapeutics?
2016-04-21,BioMarin Enrolls First Patient In Phase 1/2 Trial Of NAGLU Fusion Protein BMN 250 For Treatment Of MPS IIIB (Sanfilippo B Syndrome)
2016-04-21,Jim Cramer's Top Takeaways: Intel, BioMarin Pharmaceuticals
2016-04-20,Jim Cramer's 'Mad Money' Recap: This Market Is Rising No Matter What You Think
2016-04-20,BioMarin Provides Program Update On Vosoritide In Achondroplasia
2016-04-20,BioMarin Provides Encouraging Preliminary Data On First 8 Patients In Hemophilia A Gene Therapy Program
2016-04-18,BioMarin To Highlight Breadth Of Innovative Development Pipeline At R&D Day On April 20th In New York
2016-04-12,BioMarin To Host First Quarter 2016 Financial Results Conference Call And Webcast On Thursday, April 28 At 4:30pm ET
2016-04-12,Anavex Plays the Orphan Drug Stock Promotion Game
2016-04-07,BioMarin (BMRN) Stock is the 'Chart of the Day'
2016-04-07,BioMarin Has Juice Left in the Tank
2016-04-07,Chart of the Day: BioMarin Pharmaceutical
2016-04-01,Sell These 5 Toxic Stocks Now, Before It's Too Late
2016-03-31,Biomarin Pharmaceutical (BMRN) Strong On High Relative Volume Today
2016-03-29,3 Stocks Pushing The Drugs Industry Downward
2016-03-28,A Rolling-Nowhere Market Gathers More Bears
2016-03-24,BioMarin Receives European Orphan Drug Designation For BMN 270, First Investigational AAV-Factor VIII Gene Therapy For Patients With Hemophilia A
2016-03-22,Biomarin Pharmaceutical (BMRN) Strong On High Relative Volume Today
2016-03-21,BioMarin PKU Drug Shows Mixed Results in Pivotal Study
2016-03-21,BioMarin Phase 3 Study Of Pegvaliase For Phenylketonuria (PKU) Meets Primary Endpoint Of Blood Phenylalanine (Phe) Reduction (p
2016-03-17,Insider Trading Alert - BRT, BMRN And CSGS Traded By Insiders
2016-03-12,Biotech Stock Mailbag: Biomarin PKU Preview, Celldex Post-Mortem
2016-03-09,BMRN, INCY And ALXN, Pushing Drugs Industry Downward
2016-03-08,Jim Cramer Says BioMarin Is the Last Bear Market
2016-03-08,Jim Cramer: Bear Markets in Many Sectors Have Ended
2016-03-06,JPMorgan's 7 Best Stock Picks With Near-Term Catalysts
2016-03-03,Biomarin Drug Provides 'Substantial Benefit' to Kids with Rare, Fatal Brain Disease
2016-03-03,BioMarin To Attend Three Upcoming Investor Conferences In March
2016-03-02,BioMarin Announces Positive Data From Cerliponase Alfa Program For Treatment Of CLN2 Disease, A Form Of Batten Disease, At 12th Annual WORLDSymposium(TM) 2016
2016-03-01,BioMarin Receives Orphan Drug Designation From FDA For First AAV-Factor VIII Gene Therapy, BMN 270, For Patients With Hemophilia A
2016-02-29,BioMarin Faces a Key Test of Rare Disease Pipeline
2016-02-29,BioMarin Announces BioMarin RareConnections(TM) Rebranding And Consolidating BioMarin's Comprehensive Support And Services For Eligible Rare Disease Patients
2016-02-29,BioMarin Announces 21 Presentations At 12th Annual WORLDSymposium™ 2016 February 29-March 4 In San Diego, California: 6 Oral And 15 Poster
2016-02-25,Biomarin Pharmaceutical (BMRN) Down In After-Hours Trading
2016-02-25,BioMarin Announces Fourth Quarter And Full Year 2015 Financial Results
2016-02-17,Rally Generates Mixed Emotions So Far
2016-02-08,Trade-Ideas: Biomarin Pharmaceutical (BMRN) Is Today's Post-Market Leader Stock
2016-01-28,Today's Weak On High Volume Stock: Biomarin Pharmaceutical (BMRN)
2016-01-28,BioMarin To Host Fourth Quarter And Full Year 2015 Financial Results Conference Call And Webcast On Thursday, February 25 At 4:30pm ET
2016-01-24,Biotech Stock Mailbag: Snow Stops Sarepta's FDA Show, so What's Next?
2016-01-15,Sarepta Plunges on Harsh FDA Eteplirsen Review Ahead of Next Week's Advisory Panel Meeting
2016-01-14,Today's Dead Cat Bounce Stock Is Biomarin Pharmaceutical (BMRN)
2016-01-14,FDA Issues Complete Response Letter For KyndrisaTM For Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping
2016-01-12,Water-Logged and Getting Wetter Stock of the Day: Biomarin Pharmaceutical (BMRN)
2016-01-11,BioMarin Announces Interim Analysis Of INSPIRE Clinical Trial In Pompe Disease At 34th Annual J.P. Morgan Annual Healthcare Conference
2016-01-09,2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
2016-01-05,BioMarin To Present At 34th Annual J.P. Morgan Healthcare Conference In San Francisco
2016-01-04,BioMarin Announces Addition Of David Pyott, Former Allergan Chairman And CEO, To Company's Board Of Directors
2015-12-26,Sell These 6 Biotech Stocks Now Before It's Too Late
2015-12-19,The Naughty List: Finalists for Worst Biopharma CEO of 2015
2015-12-18,3 Drugs Stocks Pushing Industry Growth
2015-12-18,BioMarin Announces That FDA Has Advised It Will Not Take Action On The Kyndrisa™ (drisapersen) New Drug Application By The PDUFA Date
2015-12-17,3 Convertible Bonds That Belong in Your Portfolio
2015-12-17,Teva, Biomarin Offer Convertible Opportunities Says MainStay Manager
2015-12-02,Biotech Stock Mailbag: Anavex, Northwest Bio, Threshold Therapeutics
2015-11-25,Biomarin Pharmaceutical (BMRN) Down In Early Morning Trading
2015-11-25,BioMarin's Duchenne Drug Is Done, Sarepta Survives but Faces Challenge
2015-11-24,FDA Advisory Committee Discusses Clinical Data Package For BioMarin's Kyndrisa(TM) (drisapersen) For The Treatment Of Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping
2015-11-24,BioMarin Posts Presentation From FDA Advisory Committee Meeting For Kyndrisa(TM) (drisapersen) For The Treatment Of Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping
2015-11-24,BioMarin FDA Panel Live Blog
2015-11-24,BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Announced Today The Stock Is Halted
2015-11-23,NICE Recommends BioMarin's Vimizim® (elosulfase Alfa) For The Treatment Of Morquio A Syndrome In England
2015-11-20,3 Stocks to Buy on Big Volume
2015-11-20,Jim Cramer -- Market Powers Higher Despite the Woes of BioMarin, Mentor Graphics
2015-11-20,BioMarin Duchenne Drug Receives Harsh Review From FDA
2015-11-20,BioMarin Announces Data Analysis Demonstrating Consistent Efficacy Of Kyndrisa™ (drisapersen) In Comparable Patients Across Three Randomized Studies
2015-11-20,FDA Posts Briefing Documents For Advisory Committee Meeting To Review Kyndrisa™ (drisapersen) For The Potential Treatment Of Duchenne Muscular Dystrophy Amendable To Exon 51 Skipping
2015-11-20,Before the Move: Watch BioMarin Into FDA Advisory Committee
2015-11-19,These Biotech Stocks Could Move on BioMarin's Duchenne Drug FDA Panel
2015-11-18,Goldman Sees Bluebird Shares Doubling On 'One-Shot' Gene Therapy
2015-11-18,How to Prepare for BioMarin's (and Biotech's) Biggest Event of 2015
2015-11-16,Ernst & Young Names BioMarin CEO Jean-Jacques Bienaime EY Entrepreneur Of The Year® 2015 National Award Winner In Life Sciences
2015-11-04,Retrophin Sinks, Pharma Group Swings Back As Pricing Fight Escalates
2015-11-02,FDA Letter Raises Questions About Biomarin Handling of Muscular Dystrophy Drug
2015-10-29,BioMarin Announces Third Quarter 2015 Financial Results And Company Update
2015-10-27,BioMarin To Attend Upcoming Investor Conference In November
2015-10-23,Ratings Changes Today
2015-10-16,Investing Moves for a No-Growth World; ETF Distortion: Jim Cramer's Best Blogs
2015-10-16,Biotech Stock Mailbag: New Sarepta Risk, Zafgen Patient Death, Bluebird Gene Therapy Update
2015-10-15,Jim Cramer's 'Mad Money' Recap: Buy Growth Where You Can
2015-10-15,BioMarin To Host Third Quarter 2015 Financial Results Conference Call And Webcast On Thursday, October 29 At 4:30pm ET
2015-10-15,BioMarin Announces FDA Advisory Committee To Review Drisapersen For Treatment Of Patients With Duchenne Muscular Dystrophy Amenable To Exon 51 Skipping
2015-10-14,BioMarin Secures FDA Panel Date for Duchenne Drug but Where is Sarepta? (Update)
2015-10-13,Jim Cramer's Top Takeaways: Helen of Troy, BioMarin, Energy Transfer Partners
2015-10-12,BioMarin's Initial 6-Month Data From Phase 2 Study Of Vosoritide (BMN 111) In Children With Achondroplasia Presented At The American Society For Bone And Mineral Research Annual 2015 Meeting
2015-10-05,Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector
2015-10-01,BioMarin Buys Kuvan Drug Rights From Merck
2015-10-01,Sarepta Unveils New Data to Make Stronger Case for Duchenne Drug Approval
2015-10-01,BioMarin To Acquire Rights To Phenylketonuria (PKU) Franchise From Merck Serono
2015-09-30,BioMarin To Present Research Results On Duchenne Muscular Dystrophy And Pompe Disease Programs At The 20th International Congress Of The World Muscle Society
2015-09-30,BioMarin Pharmaceutical (BMRN) Stock Climbs on Patent Win
2015-09-30,Cramer -- BioMarin's Patent Win Could Spark a Biotech Bounce
2015-09-29,BioMarin Receives Favorable Ruling In The Use Of Exon 51 Antisense Oligonucleotides Patent Interference
2015-09-28,BioMarin Enrolls First Patient In Phase 1/2 Trial Of Gene Therapy Drug Candidate BMN 270 For The Treatment Of Hemophilia A
2015-09-25,RSI Alert: BioMarin Pharmaceutical Now Oversold
2015-09-25,Biotech Stock Mailbag: Rebounding From Hillary's Drug Tweet; Global Blood Weighs on Bluebird
2015-09-22,Biomarin Pharmaceutical (BMRN) Is Today's Roof Leaker Stock
2015-09-22,Analysts Say Buy Select Biotech Stocks Ahead Of Clinton Drug Plan
2015-09-18,BioMarin Announces Kuvan(R) (sapropterin Dihydrochloride) Patent Challenge Settlement
2015-09-10,Is FDA Having Trouble Setting Date for Biomarin, Sarepta Advisory Panels?
2015-09-03,Biotech Stock Mailbag: Sarepta, Biomarin, Spark, Raptor
2015-09-02,BioMarin To Attend Upcoming Investor Conferences In September
2015-09-01,BioMarin Launches KNOWyourDuchenne, Comprehensive Program For Patients With Duchenne Muscular Dystrophy To Understand Their Genetic Mutation
2015-08-31,BioMarin Announces Two Oral And 19 Poster Presentations At The Society For The Study Of Inborn Errors Of Metabolism 2015 Annual Meeting
